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Introduction
Tight junction (TJ) is the apical-most intercellular structure in epithelial cells, playing a role in cell-cell adhesion, polarity, and the permeability barrier to paracellular transport of solutes across the cells Matter et al., 2005) . The TJ creates a semipermeable barrier, separating different organ compartments. While the TJ is comprised of a large number of protein components, including membrane proteins such as occludin and cytoplasmic scaffolding proteins such as zonula occludens-1 (ZO-1), it is now well accepted that the claudin family, which has been shown to contain more than 20 members, is the main constituent of the TJ, with tissue-specific distribution of its expression. The epithelial barrier is critical to maintain tissue homeostasis; however, only a few agents that can enhance or protect epithelial barrier function have been proposed (Prosser et al., 2004; Howe et al., 2005) .
Retinoic acid (RA) is a biologically active regulator that has a broad range of functions involving cell differentiation, proliferation, and apoptosis in various cell types (Durston et al., 1989; Osanai and Petkovich, 2005) . The effects of endogenous RAs are achieved primarily by two types of RA isomers (all-trans RA [atRA] and 9-cis RA [9cRA]), which are synthesized from the retinalaldehyde precursor, a derivative of vitamin A, and are mediated by two classes of nuclear receptors, retinoic acid receptors (RARα, β, and γ) and their heterodimeric counterparts, retinoid-X-receptors (RXRα, β, and γ) (Kastner et al., 1995) . formation. One example is based on our observation that atRA plays an important role in the formation of functional TJs in F9 embryonal carcinoma cells through the involvement of specific RAR/RXR heterodimer-mediated transcription machinery (Kubota et al., 2001 ).
On the other hand, loss of expression of TJ-associated molecules such as occludin has been correlated with tumor development in carcinogenesis, and decreased and/or impaired TJ formation has been reported for various types of cancer (Tobioka et al., 2004; Osanai et al., 2006) . Interestingly, disruptions of retinoid signaling through mutations in RARs and RXRs have been shown to be associated with disorganization of epithelial architecture such as that observed in cancer tissues (de Thé, 1996) . This evidence prompted us to examine the possible hypothesis that cellular RA bioavailability may play an important role in the establishment of functional TJs in epithelial cells. Cellular RA bioavailability is regulated by the vitamin A nutritional status and the coordinated balance between RA synthesis and catabolism. RA metabolizing cytochrome P450 enzymes (CYP26s) are specifically involved in the metabolic inactivation of RA (White et al., 1997; Abu-Abed et al., 2001; Taimi et al., 2004; Osanai and Petkovich, 2005) . A member of this family, CYP26A1, has been shown to be responsible for the catabolism of atRA, and another CYP26, CYP26C1, efficiently converts both atRA and 9cRA to biologically inactive polar metabolites. The expression of CYP26s plays a critical role in embryogenesis by restricting exposure to inappropriate concentrations of RA (Abu-Abed et al., 2001) , and a state of atRA deficiency induced by enhanced expression of CYP26A1 is an important contributing factor for apoptotic resistance in certain types of cancer (Osanai and Petkovich, 2005) . Although the functional roles of CYP26s remain to be studied, RA-catabolizing enzymes play an important role on limiting the bioavailability of RA to cells and efficiently caused an RA-depleted state in given cells. By overexpressing CYP26s, we This article has not been copyedited and formatted. The final version may differ from this version. , using site-specific primers. After subcloning into a TA-cloning vector (pCRII) using a TA cloning kit (Invitrogen, Tokyo, Japan), the digested approximately 1.5, 1.3, 0.9 and1.1 Kb EcoRI-fragments were ligated into the response plasmid, pcDNA3.1(-) (Invitrogen). A CYP26C1 constitutive expression vector was also made by the insertion of full-length CYP26C1 cDNA in frame into pcDNA3.1(-). We verified the integrity of final constructs by direct sequence analysis. All primers used to make these constructs are available on request.
Five µ g of each plasmid was transfected into MDCK cells using FuGENE 6 reagent (Roche Diagnostics, Tokyo, Japan). G418 (Sigma, Tokyo, Japan)-resistant clones were expanded as a monoclonal population. Two weeks later, cell lines were selected to examine the strong expression of introduced gene by Northern blot analysis, and metabolic activities in each cell line were determined by measuring the metabolism of radiolabelled RA This article has not been copyedited and formatted. The final version may differ from this version. RT-PCR and Southern Blotting. After extraction of total RNA using TRIzol (Gibco BRL) reagent, total RNA (1 µg) was reverse-transcribed using MuLV reverse transcriptase (Applied Biosystems, Foster City, CA). For analysis of gene expression, the gene of interest was amplified from dilutions of cDNA using specific primers for between 15 and 40 cycles to define the optimal conditions for linearity to permit quantitative analysis of signal length.
As a positive control, and to confirm that each RNA sample could yield equal amounts of product after RT reactions, amplification was also done using GAPDH primers. Agarose gels were then transferred to Hybond-N+ membranes (Amersham Biosciences) and the blots were probed with the corresponding random-primed [ Experimental Murine Colitis. 2,4,6-Trinitrobenzene sulfonic acid (TNBS; Sigma) colitis was induced as described (Morris et al., 1989) . Briefly, mice were sensitized by cutaneous administration of 1% TNBS on day 1, followed by intrarectal administration of 5 µ l/g body weight of 2.5% TNBS solution on day 14. The control animals received a corresponding volume of vehicle (50% ethanol) alone. Some animals continued receiving ip administrations of a vehicle (dimethysulfoxide, DMSO), atRA (45 mg/m 2 ), or Am580 (3.75 mg/kg) every two days for 1 week. Animals received these agents as a single initial dose when TNBS was instilled intrarectally under general anesthesia. After treatment, intestinal permeability was assessed using mice that received oral gavage of FITC-dextran (4 kDa, 40 mg/kg, Sigma) 24 h before sacrificing animals. Upon death, blood was collected by cardiac puncture and the serum was immediately analyzed for FITC-derived fluorescence (WALLAC 1420, PerkinElmer). For all mice, colon length, which was defined as the distance between the most distal portion of the cecum and most terminal aspect of the rectum, was measured, and histological evaluation was done to assess the histological grading of colitis (Dieleman et al., 1998) . The maintenance and handling of animals were carried out using protocols approved by the Animal Care Facility of Sapporo Medical University.
Assessment of Bacterial Translocation.
Spleens from mice were sonicated in PBS, and small aliquots (50 µ l) of tissue homogenates were inoculated onto the bacterial agar plates.
Plates were incubated for at least 48 h at 37˚C.
Statistical Analysis. All data represent the mean ± SD of at least 3 independent experiments, each in triplicate wells. Statistical differences were analyzed using the This article has not been copyedited and formatted. The final version may differ from this version. (Fig. 1A) .
TER reached the maximum in control cells after 5 days in the presence of ~1 µ M atRA ( 
Direct Relationship Between atRA Bioavailability and Epithelial Barrier Function.
This article has not been copyedited and formatted. The final version may differ from this version. To confirm the functional relationship between the atRA bioavailability and barrier function of epithelial cells, we made various deletion mutants of CYP26A1 ( Fig. 2C ) with different catabolic activities of atRA (Fig. 2D) . Interestingly, the cells transfected with deletion mutants of CYP26A1 showed significant abrogation in decreasing TER (Fig. 2E) and increasing paracellular flux (Fig. 2F ) mediated by metabolic inactivation of atRA contained in the media, which was clearly associated with the catabolic activities of atRA.
These data support our novel concept that atRA bioavailability in the cells is an important contributing factor for determining the epithelial barrier of TJs.
RARα Is an Alternative Regulator to Barrier Function. To utilize the substrate specificities of CYP26A1 and C1, we next investigated the role of 9cRA in barrier function.
9cRA could enhance the barrier function and the cells with forced expression of CYP26C1 showed significant inhibition of the increasing effects of TER mediated by both atRA and 9cRA (Fig. 3A) . Pre-treatment with ketoconazole partially abrogated this CYP26C1-mediated effect (Fig. 3B) . TER recovered ~59% in CYP26A1-expressing cells This article has not been copyedited and formatted. The final version may differ from this version. is consistent with the previous observation that CYP26C1 was less sensitive than CYP26A1
to the inhibitory effects of ketoconazole (Taimi et al., 2004) . CYP26A1 overexpression in MDCK cells did not have any effect on the 9cRA-mediated increase of TER (Fig. 3C) , suggesting that RXRs activated by 9cRA were also involved in the regulation of the epithelial barrier.
We next used various types of synthetic retinoids to specifically stimulate and inhibit RAR and RXR subtypes to confirm the involvement of RARs and RXRs in the regulation of barrier function. RAR and RXR antagonists partially abrogated atRA-and 9cRA-mediated changes of permeability (Fig. 3, D and E), suggesting that both RARs and RXRs were involved in the regulation of epithelial permeability. The synthetic compounds Am80 (4 [(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl) carbamoyl]benzoic acid) and Am580 (4(5, 6, 7, 5, 8, benzoic acid), which are resistant to metabolism by CYP26s, were reported to stimulate RARα selectively as efficiently as atRA (Luu et al., 2001) . In the dose range from 2.5 to 100 nM, a clear dose dependence of enhancement was found even in the CYP26A1-overexpressing MDCK cells that were treated with Am80 and Am580 (Fig. 3, D and E, and data not shown). While we could not exclude the participation of the definite RXR subtypes responsible for the modulation of barrier function due to the lack of specific agonists or antagonists for RXRs, the RARα agonists were, at lease in part, clearly involved in the regulation of barrier function.
We further examined whether atRA attenuated the epithelial damages induced by various stimuli such as hyperthermia and oxidative stress mediated by H 2 O 2 . We exposed these insults to the epithelial monolayer and showed that atRA was partially but significantly This article has not been copyedited and formatted. The final version may differ from this version. (Fig. 4, A and B) . We observed similar effect on epithelial monolayer by using Am580 (data not shown), suggesting a possible feasibility of RARα-mediated therapy for diseases that are characterized by epithelial hyperpermeability.
TJ-associated Genes Are Regulated by Cellular atRA Bioavailability. We next examined whether changes in barrier function regulated by RA bioavailability in the cell were accompanied by gene-expression alterations of TJ-associated genes. We first examined the quantitativeness of our method, and found that the threshold cycling parameter for saturation of band intensity showed a clear inverse proportion to the template (Fig. 5A ), indicating that our assay was sensitive to examine the quantification of mRNA expression.
Due to the limited availability of the canine cDNA sequence of TJ-associated genes, we analyzed genes known to be cloned such as occludin, claudin-1, claudin-4, and ZO-1 (Fig.   5B ). Treatment with atRA significantly upregulated these genes in a time-dependent manner, and CYP26A1-mediated depletion of atRA partially abrogated this induction.
Although the basal levels of gene expression were different between MDCK Vec and MDCK CYP26A1 cells, there was evidence that normal FBS contained a physiological dose of atRA, which was sufficient for gene-expression of the TJ-associated genes and functions of TJ (Fig. 2E ). In addition, the TJ protein kinetics in the event of atRA treatment was consistent with the gene-expression alterations of TJ-associated genes (Fig. 5C ).
Treatment with siRNA targeted to occludin did not change the epithelial permeability in MDCK monolayer (data not shown), which was consistent with the evidence that the claudin family is the main constituent for TJ, rather than occludin Matter et al., 2005) . However, it is agreeable that increased expression of TJ-associated This article has not been copyedited and formatted. The final version may differ from this version. genes potentially associated with the RA-mediated enhancement of barrier function, because of our previous study demonstrating the direct mechanistic link between atRA-mediated inductions of TJ-associated genes and the formation of functional TJs in F9 cells (Kubota et al., 2001 ).
RA-mediated Enhancement of Epithelial Barrier Protects Mice from Colitis. As RARα
is an important determinant for epithelial barrier in vitro, we employed TNBS-induced murine experimental colitis to examine the clinical relevance of RARα agonists. We first measured the body weight, because weight loss is a reliable method to the severity of TNBS colitis (Morris et al., 1989) . Control mice lost body weight rapidly and failed to regain the weight during the course of the 7-day experiment, whereas atRA and Am580-treated animals did not show significant weight loss (Fig. 6A) . Similarly, the length of the colon, which shortens as a result of more severe inflammation, was significantly different between the control and RA treated groups, in which animals treated with the vehicle showed significant shortening of the colon, whereas those treated with atRA and Am580 did not display severe shortening (Fig. 6B ). In addition, as assessed by 4 kDa FITC-dextran, treatment with atRA and Am580 significantly abrogated the increase in intestinal permeability observed in mice with vehicle treatment (Fig. 6C) . Furthermore, bacterial translocation, a measure of intestinal barrier integrity, was found in the spleens of TNBS-treated animals and was correlated with the permeability of FITC-dextran (Fig. 6D ). Am580 was more effective for these parameters than atRA. Histologically, the colons were characterized by extensive ulceration with severe mucosal inflammation, multifocal dropouts of entire crypts in all parts of the colon, and extensive edema in vehicle-treated mice; however, mucosal injuries were markedly attenuated by the treatment with atRA and Am580, with slight amounts of This article has not been copyedited and formatted. The final version may differ from this version. (Fig. 6E ). Histological grading of colitis clearly demonstrated these differences between mice treated with RA and untreated control animals ( Fig. 6F) , suggesting that RA served an important barrier-protective mechanism for the severity of colitis by regulating epithelial integrity.
This article has not been copyedited and formatted. The final version may differ from this version. Our present study with TNBS colitis revealed a potentially central role for RA as an endogenous regulator of inflammatory colitis, providing a significant insight into the molecular details linking retinoid action to the pathology of diseases with gut hyperpermeability.
Given the complexity of the cell signaling events regulating epithelial permeability (Prasad et al., 2005; Gordon et al., 2005) , it is not surprising that RAs modulate various sets of genes, including occludin and claudins. While a previous report has demonstrated that the human occludin promoter is downregulated by inflammatory cytokines such as tumor necrosis factor α and interferon γ (IFN γ ), which may be an important mechanism in gastrointestinal diseases accompanied by barrier defects (Mankertz et al., 2000) , this is the This article has not been copyedited and formatted. The final version may differ from this version. report demonstrating that RARα stimulation preferentially could enhance the expression of TJ-associated genes such as occludin. This mechanism is partially explained by our preliminary study of the occludin promoter using approximately 2.5 kb upstream from the transcription initiation site, suggesting that RARα agonists stimulate occludin expression at the transcriptional level (our unpublished result). We cannot conclude from our present study whether the RA effect is direct on the epithelial integrity, whereas our observation may support the plausible hypothesis that strategies that increase RA bioavailability in epithelial cells may be promising to ameliorate intestinal morbidity in many intestinal disorders in which elevated levels of cytokines result in gut barrier dysfunction. This is consistent with epidemiological studies showing that vitamin A supplementation significantly reduces the childhood mortality caused by the persistent diarrhea with inflammatory bowel diseases (Sommer et al., 1986; McCullough et al., 1999) .
Previous reports have shown the functional RA deficiency in a variety of tissues in pathological settings, and demonstrated that RA depletion drives opening of paracellular pathways in epithelial cells as observed in cancer cells. Our results suggest that impaired RA signaling caused by RA depletion leads to the disruption of functional TJs. It is thus interesting to speculate that strategies designed to enhance RA signals and/or blockade RA catabolism may be of therapeutic value in intestinal diseases that have increased gut permeability. However, in acute responses to infection, increased permeability may have a protective function in the gut (Grencis and Bancroft, 2004) . Better understanding of the mechanisms that regulate epithelial integrity may provide valuable insights into various intestinal disorders (McCullough et al., 1999) . Interestingly, altered gut permeability may not be simply due to TJ-associated gene-expression alterations but also to deregulated phosphorylation, disruption of distribution, and vacuolarization of TJ proteins (Clayburgh et This article has not been copyedited and formatted. The final version may differ from this version. ). This evidence suggests that the functional TJ is governed by complex regulation in response to a wide variety of pathological insults, and future work may reveal more detailed mechanisms explaining how RAs maintain epithelial integrity and potentially attenuate mucosal damage.
Vitamin A is especially critical for gut immunity, and its deficiency results in deregulated production of cytokines such as IFN-γ and impaired antibody responses (Cantorna et al., 1994) . Since the intestinal mucosa is an enriched source of cytokines that are secreted from various immunological cell types, the role of the immune system is likely to generate an aggressive physiological response to the imbalance induced by the barrier dysfunction because intestinal epithelial cells interface directly with various potentially harmful antigens (Stober et al., 2003) . A number of studies have shown that RA attenuates inflammation-related epithelial damage in mouse colon (Atreya et al., 2000; Gordon et al., 2005) . Although it is impossible to conclude if such attenuation is due to non-specific anti-inflammatory effects of RA or it is determined by a direct protective action of RA on mucosal epithelium, we clearly demonstrated that RARα stimulation was able to attenuate the disruption of barrier properties of MDCK monolayer induced by the pathological insults such as oxidative stress and hyperthermia, providing a logical connection between in vitro experiments and the in vivo study. It is therefore noteworthy to expect that high RA bioavailability in the intestinal microenvironment preferentially affects gut epithelium, resulting in a reduced incidence of life-threatening epithelial hyperpermeability of the gut.
It is clear that the peroxisome proliferator-activated receptor gamma (PPARγ) ligands such as n-3 polyunsaturated fatty acids (PUFA) play an anti-inflammatory role for This article has not been copyedited and formatted. The final version may differ from this version. modulating mucosal immunity in an animal model of inflammatory bowel disease (Su et al., 1999; Rogler 2006) , but also that RAR activation may compete with RXR, decreasing activation of PPARγ/RXR heterodimer. While this potential competition and paradoxical therapeutic effects of RAR and PPARγ activation after vitamin A and PUFA supplementation should be addressed in the future study, one possible explanation is that the ligand-mediated gene expression appears to be made depending on the cell type, pharmacokinetics of the ligands, relative abundance of nuclear receptors, extent of the competition or cross-talk among nuclear transcription factors, and the modulating role of coactivators and corepressors on ligand-dependent transcription. In addition, it is unlikely that only a limited number of transcriptional machinery and signaling is available in a given tissue. Whether definite nuclear receptor(s) responsible for maintaining the intestinal microenvironment remains to be examined, RARα is, at least in part, an important determinant for the epithelial integrity.
Morphological examinations using immunohistochemistry insufficiently represented the observed differences of barrier functions between control and RA-treated MDCK cells, in animals with colitis as well. This observation supports a previously proposed concept that barrier integrity can be significantly compromised with no observable changes in morphological architecture (Karhausen et al., 2004) . Another example is presented by the observation that bacterial colonization of the proximal gut leads to a leaky intestine even without apparent mucosal damage (Asfaha et al., 2001) . Alternatively, a possible explanation has emerged from the accumulated evidence that MDCK cells display highly differentiated cellular phenotypes, expressing abundant endogenous TJ-associated proteins in cell-cell junctions ).
Our present study indicates that RA provides barrier-protective elements to the epithelial cell in inflammatory mucosal injuries. Studies along this line will help us to This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version. 
